TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 173 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 4.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,434,000 | -27.1% | 351,350 | +29.5% | 2.53% | +7.3% |
| Q4 2021 | $12,943,000 | -28.2% | 271,350 | 0.0% | 2.36% | -15.6% |
| Q3 2021 | $18,026,000 | -14.2% | 271,350 | +0.8% | 2.80% | -19.0% |
| Q2 2021 | $21,002,000 | -17.5% | 269,186 | 0.0% | 3.45% | +7.8% |
| Q1 2021 | $25,462,000 | -66.2% | 269,186 | -56.4% | 3.20% | -50.8% |
| Q4 2020 | $75,226,000 | +179.0% | 617,372 | +100.0% | 6.50% | 0.0% |
| Q3 2020 | $26,967,000 | +35.3% | 308,686 | 0.0% | 6.50% | +22.6% |
| Q2 2020 | $19,938,000 | +44.6% | 308,686 | 0.0% | 5.30% | -37.1% |
| Q1 2020 | $13,786,000 | – | 308,686 | – | 8.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |